Name: Name:S 3304
Brand: Angene
SKU: AG00292E
Rating: 90 (10 reviews)

S 3304

CAS No.:

203640-27-1

Catalog Number:

AG00292E

Molecular Formula:

C24H20N2O4S2

Molecular Weight:

464.5566

Pack Size

Purity

Availability

Location

Price(USD)

Quantity

1mg

98%

1 week

United States

$210

- +

5mg

98%

1 week

United States

$515

- +

10mg

98%

1 week

United States

$821

- +

25mg

98%

1 week

United States

$1585

- +

50mg

98%

1 week

United States

$2348

- +

Product Description

Catalog Number:

AG00292E

Chemical Name:

S 3304

CAS Number:

203640-27-1

Molecular Formula:

C24H20N2O4S2

Molecular Weight:

464.5566

MDL Number:

MFCD22200275

IUPAC Name:

(2R)-3-(1H-indol-3-yl)-2-[[5-[2-(4-methylphenyl)ethynyl]thiophen-2-yl]sulfonylamino]propanoic acid

InChI:

InChI=1S/C24H20N2O4S2/c1-16-6-8-17(9-7-16)10-11-19-12-13-23(31-19)32(29,30)26-22(24(27)28)14-18-15-25-21-5-3-2-4-20(18)21/h2-9,12-13,15,22,25-26H,14H2,1H3,(H,27,28)/t22-/m1/s1

InChI Key:

YWCLDDLVLSQGSZ-JOCHJYFZSA-N

SMILES:

OC(=O)[C@H](NS(=O)(=O)c1ccc(s1)C#Cc1ccc(cc1)C)Cc1c[nH]c2c1cccc2

UNII:

BK459F050X

Properties

Complexity:

835

Compound Is Canonicalized:

Yes

Covalently-Bonded Unit Count:

Defined Atom Stereocenter Count:

Defined Bond Stereocenter Count:

Exact Mass:

464.086g/mol

Formal Charge:

Heavy Atom Count:

Hydrogen Bond Acceptor Count:

Hydrogen Bond Donor Count:

Isotope Atom Count:

Molecular Weight:

464.554g/mol

Monoisotopic Mass:

464.086g/mol

Rotatable Bond Count:

Topological Polar Surface Area:

136A^2

Undefined Atom Stereocenter Count:

Undefined Bond Stereocenter Count:

XLogP3:

Literature

Title	Journal
Pharmacokinetics and safety assessments of high-dose and 4-week treatment with S-3304, a novel matrix metalloproteinase inhibitor, in healthy volunteers.	British journal of clinical pharmacology 20070501
Safety, tolerability and pharmacokinetics of oral S-3304, a novel matrix metalloproteinase inhibitor, in single and multiple dose escalation studies in healthy volunteers.	International journal of clinical pharmacology and therapeutics 20050601

Properties